ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Cabotegravir Ultra Long-acting (CAB ULA) Following Switch From Cabotegravir Long-acting (CAB LA) in Healthy Adults

ViiV Healthcare · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
hivinfectionspharmacokineticssafety
hiv infections, cabotegravir (cab), ultra long acting (ula), long acting (la), pharmacokinetics, safety, tolerability, healthy adult, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 888419
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.